Skip to content

Prostate Cancer Utilities and Cost-Effectiveness Analysis

Prostate Cancer Utilities and Cost-Effectiveness Analysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00203918
Enrollment
481
Registered
2005-09-20
Start date
2004-01-31
Completion date
2013-02-28
Last updated
2017-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate Cancer, Cost-Effectiveness Analysis, Utility Assessment

Brief summary

The purpose of this study is to help doctors and patients make better decisions about prostate cancer treatment. This research is being done because we do not know how patient preferences for health states related to prostate cancer affect the final treatment decision.

Detailed description

The goal of this project is to incorporate patients' preferences into a previously developed prostate cancer treatment decision-model and to understand the implications for doing so for cost-effectiveness analysis. To do this, it is first necessary to obtain patient utility scores (i.e., patient preference weights). To do this we will perform a survey of patients visiting the urology clinic to undergo prostate biopsies to validate a method of utility assessment, and understand the patients' individual evaluations of treatment-related health studies. We will also ask patients questions relating to their anxiety levels concerning the possible diagnosis of prostate cancer.

Interventions

BEHAVIORALSurvey, interview

A survey is administered to patients visiting the urology clinic to undergo prostate biopsies to validate a method of utility assessment, and understand patients' individual evaluations of treatment-related health states. Medical records will also be reviewed 00 days after the survey was administered to determine whether this data reflects actual treatment decisions.

BEHAVIORALpatient utility scores (i.e. patient preference weights)

comparison of patient preferences

Sponsors

University of Chicago
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing prostate biopsy

Exclusion criteria

* Women and children will be excluded, as prostate cancer occurs in men only * Diagnosis of dementia

Design outcomes

Primary

MeasureTime frameDescription
Utility scores for treatment outcomes90 days after enrollmentPatient utility scores (i.e. patient preference weights) are calculated using survery data will determine which prostate cancer treatment would be most cost-effective for each subject. Patients will be contacted by phone and patient records will be reviewed 90 days after the survey has been completed to determine whether this data reflects actual treatment decisions.

Secondary

MeasureTime frameDescription
Anxiety levels90 days after enrollmentWe will also ask patients questions relating to their anxiety levels concerning the possible diagnosis of prostate cancer.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026